PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsperipheral vascular diseases
MeSH D016491 - peripheral vascular diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D014652:Vascular diseases
1 Company
1 Drug
$
Success rate
D016491: 
Peripheral vascular diseases
46 Companies
23 Drugs
$
Success rate
D004916:Erythromelalgia
0 Companies
0 Drugs
Success rate
D010689:Phlebitis
0 Companies
0 Drugs
Success rate
D011928:Raynaud disease
30 Companies
5 Drugs
$
Success rate
D018438:Blue toe syndrome
0 Companies
0 Drugs
Success rate
D054068:Livedo reticularis
0 Companies
0 Drugs
Success rate
D058729:Peripheral arterial disease
4 Companies
2 Drugs
$
Success rate
D062108:May-thurner syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaCilostazol Cilostazol  2005-03-01   
Clopidogrel Clopidogrel Teva (hydrogen sulphate)  2009-07-27   
Clopidogrel Clopidogrel Teva Pharma (previously Clopidogrel HCS)  2009-09-21   
Clopidogrel Clopidogrel ratiopharm  2015-02-18   
Niacin Niacin  1982-01-01   
Clopidogrel Clopidogrel Teva Generics B.V  2010-10-28   
Clopidogrel Clopidogrel Teva Pharma B.V  2011-06-16   
Rising PharmaceuticalsCilostazol Cilostazol  2006-04-20   
Niacin Niacin  2019-02-22   
MylanClopidogrel Clopidogrel DURA  2009-07-21   
RocheFolic acid, Dexpanthenol, Ascorbic acid, Cyanocobalamin, Ergocalciferol, Vitamin a, Biotin, Niacinamide, Pyridoxine, Riboflavin, Thiamine Berocca Pn  1985-10-10   
Chartwell PharmaceuticalsNiacin Niacin  2014-03-20   
Cilostazol Cilostazol  2012-09-24   
SandozFolic acid, Dexpanthenol, Ascorbic acid, Cyanocobalamin, Vitamin a, Alpha-tocopherol, Biotin, Cholecalciferol, Niacinamide, Pyridoxine, Riboflavin, Thiamine, Tocopherol Infuvite  2000-05-18   
Niacin Niacin  1982-01-01   
AbbVieNiacin Niaspan Titration Starter Pack  1997-07-28   
AstraZenecaTicagrelor Brilique  2010-12-03   
Ticagrelor Possia  2010-12-03   
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
57%
4/7
Phase 2
65%
13/20
Phase 3
35%
12/34
Approved: 6Overall Success rate: 13%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Cilostazol,
Clopidogrel
Mylan
Clopidogrel
GSK
Epoprostenol
Roche
Ascorbic acid,
Biotin,
Cyanocobalamin,
Dexpanthenol,
Ergocalciferol,
Folic acid,
Pyridoxine,
Riboflavin,
Vitamin a
AstraZeneca
Ticagrelor
Sanofi
Clopidogrel,
Niacin,
Niacinamide,
Riferminogene pecaplasmid,
Sodium chloride,
Sodium lactate,
Microcrystalline cellulose
1
2
3
4
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use